$PULM
Pulmatrix Inc

2015 Q2 Form 10-K Financial Statement

#000114420415036361 Filed on June 10, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2015
Revenue $170.0K $105.0K $1.201M
YoY Change 241.19%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.880M $1.300M $4.530M
YoY Change 847.27% 94.03% 160.94%
% of Gross Profit
Research & Development $1.610M $918.0K $7.187M
YoY Change -6.88% 186.88% 9.06%
% of Gross Profit
Depreciation & Amortization $120.0K $62.00K $232.0K
YoY Change -32.16%
% of Gross Profit
Operating Expenses $11.49M $2.852M $24.22M
YoY Change 368.75% 188.08% 156.88%
Operating Profit -$11.32M -$2.747M -$23.02M
YoY Change 361.81% 153.61%
Interest Expense $327.0K $184.0K $953.0K
YoY Change -94.17% -93.76%
% of Operating Profit
Other Income/Expense, Net $29.00K -$44.00K
YoY Change 625.0% 1366.67%
Pretax Income -$14.90M -$1.550M -$26.17M
YoY Change 766.28% 56.57% 291.14%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$14.90M -$1.803M -$26.17M
YoY Change 114.62% 82.12% 8.38%
Net Earnings / Revenue -8762.94% -1717.14% -2178.77%
Basic Earnings Per Share
Diluted Earnings Per Share -$26.61M -$7.750M -$32.31M
COMMON SHARES
Basic Shares Outstanding 4.804M shares 4.804M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.51M $10.36M $18.90M
YoY Change 78.77% -33.46% 82.43%
Cash & Equivalents $25.51M $2.745M $18.90M
Short-Term Investments
Other Short-Term Assets $510.0K $114.0K $1.560M
YoY Change 920.0% 11300.0% 875.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $26.02M $10.52M $20.46M
YoY Change 77.66% -32.43% 94.49%
LONG-TERM ASSETS
Property, Plant & Equipment $545.0K $157.0K $690.0K
YoY Change 18066.67% 7750.0% 331.25%
Goodwill $15.94M
YoY Change
Intangibles $7.534M
YoY Change
Long-Term Investments
YoY Change
Other Assets $22.00K $250.0K
YoY Change
Total Long-Term Assets $24.30M $157.0K $24.41M
YoY Change 809766.67% 7750.0% 15156.25%
TOTAL ASSETS
Total Short-Term Assets $26.02M $10.52M $20.46M
Total Long-Term Assets $24.30M $157.0K $24.41M
Total Assets $50.31M $10.68M $44.87M
YoY Change 243.5% -31.43% 320.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $314.0K $1.090M
YoY Change
Accrued Expenses $1.013M $640.0K $1.490M
YoY Change 87.59% 56.1% 132.81%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.030M
YoY Change
Total Short-Term Liabilities $1.327M $635.0K $3.610M
YoY Change 141.27% -32.95% 464.06%
LONG-TERM LIABILITIES
Long-Term Debt $6.706M $0.00 $5.690M
YoY Change
Other Long-Term Liabilities $10.00K $10.00K
YoY Change
Total Long-Term Liabilities $6.706M $0.00 $5.700M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.327M $635.0K $3.610M
Total Long-Term Liabilities $6.706M $0.00 $5.700M
Total Liabilities $11.00M $640.0K $12.27M
YoY Change 1900.55% -32.63% 1817.19%
SHAREHOLDERS EQUITY
Retained Earnings -$118.6M -$10.36M
YoY Change 2103.47% 182.37%
Common Stock $157.9M $20.41M
YoY Change 32905108.33% 11.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $39.31M $10.05M $32.61M
YoY Change
Total Liabilities & Shareholders Equity $50.31M $10.68M $44.87M
YoY Change 243.5% -31.43% 320.13%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2015
OPERATING ACTIVITIES
Net Income -$14.90M -$1.803M -$26.17M
YoY Change 114.62% 82.12% 8.38%
Depreciation, Depletion And Amortization $120.0K $62.00K $232.0K
YoY Change -32.16%
Cash From Operating Activities -$6.080M -$1.160M -$12.47M
YoY Change 270.73% -16.55% 131.35%
INVESTING ACTIVITIES
Capital Expenditures -$50.00K $19.00K $266.0K
YoY Change -5100.0% -6.67%
Acquisitions
YoY Change
Other Investing Activities $9.670M $9.670M
YoY Change
Cash From Investing Activities $9.620M -$60.00K $9.410M
YoY Change -5981.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $35.00K
YoY Change
Cash From Financing Activities 21.52M 0.000 21.52M
YoY Change 6229.41% -100.0% 6421.21%
NET CHANGE
Cash From Operating Activities -6.080M -1.160M -12.47M
Cash From Investing Activities 9.620M -60.00K 9.410M
Cash From Financing Activities 21.52M 0.000 21.52M
Net Change In Cash 25.06M -1.220M 18.46M
YoY Change -2027.69% -107.84% -453.64%
FREE CASH FLOW
Cash From Operating Activities -$6.080M -$1.160M -$12.47M
Capital Expenditures -$50.00K $19.00K $266.0K
Free Cash Flow -$6.030M -$1.179M -$12.74M
YoY Change 267.46% -15.18% 124.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1427000 USD
CY2015Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3490000 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
635000 USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3140250 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3785533 shares
CY2014Q1 us-gaap Cash
Cash
15571000 USD
CY2015Q1 us-gaap Cash
Cash
10357000 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3000 USD
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
166000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
15574000 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
10523000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2000 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
157000 USD
CY2014Q1 us-gaap Assets
Assets
15576000 USD
CY2015Q1 us-gaap Assets
Assets
10680000 USD
CY2014Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
410000 USD
CY2015Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
635000 USD
CY2014Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
537000 USD
CY2015Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
947000 USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
465 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
480 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
18297535 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
81522 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
315836 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20404520 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3669000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10360000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
14629000 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
10045000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15576000 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10680000 USD
CY2015Q1 rtgn Working Capital
WorkingCapital
9888000 USD
CY2015Q1 us-gaap Prepaid Insurance
PrepaidInsurance
12000 USD
CY2015Q1 us-gaap Other Assets Current
OtherAssetsCurrent
114000 USD
CY2015Q1 us-gaap Prepaid Rent
PrepaidRent
2000 USD
CY2015Q1 rtgn Other Prepaid Expenses And Current Assets
OtherPrepaidExpensesAndCurrentAssets
38000 USD
CY2015Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
92000 USD
CY2015Q1 rtgn Accrued Director Compensation
AccruedDirectorCompensation
43000 USD
CY2015Q1 rtgn Accrued Legal Fees
AccruedLegalFees
144000 USD
CY2015Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
50000 USD
CY2014Q1 rtgn Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
9000 USD
CY2015Q1 rtgn Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
128000 USD
CY2014Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
14000 USD
CY2015Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
32000 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
3145650 shares
CY2015 rtgn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerms
P1Y1M6D
CY2015Q1 rtgn Share Based Compensation Arrangement By Share Based Payment Award Equity Instrument Other Than Options Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentOtherThanOptionsEquityInstrumentsExercisableNumber
3140250 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0167 pure
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M10D
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.95 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
332500 shares
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
16664 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.37
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.37
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.37
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.37
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y8M12D
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1079000 USD
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4804290 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4804290 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4650000 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4650000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.79
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1593000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
452000 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1060000 USD
CY2015 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2014 us-gaap Revenues
Revenues
0 USD
CY2015 us-gaap Revenues
Revenues
0 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1382000 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2178000 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1736000 USD
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4530000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
3118000 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
6708000 USD
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.53
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.39
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2036301 shares
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4823907 shares
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
47000 USD
CY2015 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
1028000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1079000 USD
CY2014 us-gaap Depreciation
Depreciation
2000 USD
CY2015 us-gaap Depreciation
Depreciation
1000 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2014 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1000 USD
CY2015 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
163000 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
146000 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
388000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2969000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5386000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
156000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-156000 USD
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1453000 USD
CY2015 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2014 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
916000 USD
CY2015 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
537000 USD
CY2015 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-5214000 USD
CY2015 rtgn Gross Proceeds From Issuance Of Common Stock And Warrants
GrossProceedsFromIssuanceOfCommonStockAndWarrants
1117000 USD
CY2014 rtgn Offering Cost
OfferingCost
3195000 USD
CY2015 rtgn Offering Cost
OfferingCost
252000 USD
CY2014 rtgn Offering Cost Withheld From Proceeds
OfferingCostWithheldFromProceeds
2826000 USD
CY2014 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
206000 USD
CY2015 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
163000 USD
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Entity Registrant Name
EntityRegistrantName
Ruthigen, Inc.
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001574235
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q3 dei Entity Public Float
EntityPublicFloat
13572764 USD
CY2015 dei Trading Symbol
TradingSymbol
RTGN
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4804290 shares
CY2014 rtgn Investment From Former Parent
InvestmentFromFormerParent
1679000 USD
CY2014 rtgn Accrued Offering Costs
AccruedOfferingCosts
163000 USD
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i>Concentration of Credit Risk</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Financial instruments that potentially subject the Company to concentrations of credit risk include amounts held as cash. Cash is maintained in financial institutions located in the United States. The Company is exposed to credit risk in the event of default by these financial institutions for amounts in excess of the Federal Deposit Insurance Corporation insured limits.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4000 USD
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
160000 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2000 USD
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3000 USD
CY2014Q1 rtgn Accrued Franchises Taxes
AccruedFranchisesTaxes
0 USD
CY2015Q1 rtgn Accrued Franchises Taxes
AccruedFranchisesTaxes
146000 USD
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0 pure
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1031000 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1754000 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-182000 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-309000 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1213000 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2063000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1427000 USD
CY2015Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3224000 USD
CY2014Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
0 USD
CY2015Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
262000 USD
CY2014Q1 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
0 USD
CY2015Q1 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
4000 USD
CY2014Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
1427000 USD
CY2015Q1 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
3490000 USD
CY2014Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2015Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.060 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.060 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.003 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.013 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.001 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.025 pure
CY2014 rtgn Effective Income Tax Rate Reconciliation Nondeductible Expense Merger Expenses Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMergerExpensesPercent
0.0 pure
CY2015Q1 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
995 sqft
CY2015Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1700 USD
CY2015 rtgn Effective Income Tax Rate Reconciliation Nondeductible Expense Merger Expenses Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMergerExpensesPercent
0.004 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.390 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.308 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1213000 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-2063000 USD
CY2014Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
2539000 USD
CY2015Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
8059000 USD
CY2015 rtgn Operating Loss Carryforwards Expiration Period
OperatingLossCarryforwardsExpirationPeriod
2033
CY2013Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-2.5
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2013Q3 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
2000000 shares
CY2014Q1 invest Investment Warrants Exercise Price
InvestmentWarrantsExercisePrice
0.0001
CY2014Q1 rtgn Closing Price Of Common Stock Percentage
ClosingPriceOfCommonStockPercentage
1.5 pure
CY2015 rtgn Class Of Warrant Or Right Duration From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRightDurationFromWhichWarrantsOrRightsExercisable
P1Y
CY2015 rtgn Percentage Of Options Unvested
PercentageOfOptionsUnvested
0 pure
CY2015Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.17 pure
CY2015 rtgn Proceeds From Transfer Atleast For Not Consummated
ProceedsFromTransferAtleastForNotConsummated
3800000 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
20000 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
20000 USD
CY2014 rtgn Initial Public Offerinfg Value Of Units
InitialPublicOfferinfgValueOfUnits
16021000 USD
CY2014 rtgn Change In Available Nol Due To Deconsolidation
ChangeInAvailableNolDueToDeconsolidation
0.0 pure
CY2015 rtgn Change In Available Nol Due To Deconsolidation
ChangeInAvailableNolDueToDeconsolidation
0.062 pure

Files In Submission

Name View Source Status
0001144204-15-036361-index-headers.html Edgar Link pending
0001144204-15-036361-index.html Edgar Link pending
0001144204-15-036361.txt Edgar Link pending
0001144204-15-036361-xbrl.zip Edgar Link pending
ex10-25logo.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rtgn-20150331.xml Edgar Link completed
rtgn-20150331.xsd Edgar Link pending
rtgn-20150331_cal.xml Edgar Link unprocessable
rtgn-20150331_def.xml Edgar Link unprocessable
rtgn-20150331_lab.xml Edgar Link unprocessable
rtgn-20150331_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending
v412118_10k.htm Edgar Link pending
v412118_ex10-23.htm Edgar Link pending
v412118_ex10-24.htm Edgar Link pending
v412118_ex10-25.htm Edgar Link pending
v412118_ex10-26.htm Edgar Link pending
v412118_ex21.htm Edgar Link pending
v412118_ex23-1.htm Edgar Link pending
v412118_ex31-1.htm Edgar Link pending
v412118_ex31-2.htm Edgar Link pending
v412118_ex32.htm Edgar Link pending